medigraphic.com
ISSN 2448-8909 (Print)

2013, Number 1

<< Back Next >>

Med Crit 2013; 27 (1)

Epileptic seizure (status epilepticus): Neurological emergency

García S, Sauri SS, Meza E, Villagómez-Ortiz AJ

Language: Spanish
References: 50
Page: 43-52
PDF size: 114.51 Kb.


ABSTRACT

Status epilepticus is a neurologic emergency associated with significant morbility and mortality. Status epilepticus is when seizure last 30 minutes or when a patient has two o more sequential crisis without a full recovery of consciousness between episodes. Ten percent in average of the patients with epilepsy could suffer status epilepticus, the more frequent etiology is caused by stop drugs for treatment of epilepsy, metabolic abnormalities, other etiologies are anoxia, stroke, metabolic abnormalities, head injury, neuroinfections. In order to get better results is nedeed an appropriate treatment in a specialized unit with trained personal in the attention of this patients, in fact now a days the mortality is around 20%.


REFERENCES

  1. Hauser WA. Status epilepticus; frequency, etiology and neurologic sequelae. In: Delgado Escueta AV, Wajterlain CG, Treiman DM, Porter RJ. Status epilepticus: mechanisms of brain damage an treatmen. New York:Raven Press 1982:3-14.

  2. De Lorenzo RJ. Status epilepticus. Concepts in diagnosis and treatment. Semin Neurolo 1990;2:296-405.

  3. Otero-Siliceo. Status epilepticus. En: Velasco Feria A, Martinez Muñoz D, Rubio Donadieu F. Epilepsia, aspectos neurobiológicos, médicos y sociales. México:INNN-UNAM 1997:230-257.

  4. Hunter R. Status epilepticus: history, incidence and problems. Epilepsia 1959;1:162-188.

  5. García Ramos GS, Niño-Cruz JA. Estado epiléptico. En: Estañol-Vidal B, Ramiro HM. Temas de Medicina Interna. Terapéutica neurológica. México, ed. Mc Graw Hill, 1996;4(4):807-817.

  6. Treiman DM, DeGiorgio CM, Salisbury SM, Wickboldt CL. Subtle generalized convulsive status epilepticus. Epilepsia 1984;25:653.

  7. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiological studies on epilepsy. Epilepsia 1993;34:592-596.

  8. De Lorenzo RJ, Towne AR, Ko D, Driscoll S. Mortality and seizure duration in status epilepticus. Ann Neuro 1987;22:132-135.

  9. Kälviäinen R, Eriksson K, Parviainen I. Refractory generalised convulsive status epilepticus: a guide to treatment.CNS Drugs 2005;19(9):759-768.

  10. Commission for the control of Epilepsy and Its consequences. Plan for nationwide Action on Epilepsy. Bethesda. US:Deparment of health, education and welfare,1997.

  11. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990;40(suppl 2):9-13.

  12. Maytal J, Shinnar S, Moshe SL. Low mortality and morbidity of status epilepticus in children. Pediatrics 989;83:23-325.

  13. Hesdorffer DC, Logroscino G, Cascino G, Annegers F, Hauser WA. Incidence of status epilepticus in Rochester Minnesota, 1965-1984. Neurology 1998;50:735-742.

  14. De Lorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond Virginia. Neurology 1996;446:1029-1035.

  15. Delgado-Escueta A, Tulio-Medina M, Durón-Martínez R. Status epilepticus: Epidemiología, clasificación y tratamiento. En: Primer Congreso Virtual Iberoamericano de Neurología; del 15 de octubre al 30 de noviembre de 1998. Disponible en: http://www.uninet.edu/neurocon/congreso-1/conferencias/epilepsia-9.html

  16. Delgado Escueta AV, Bajorek JG. Status epilepticus: mechanisms of brain damage and rational management. Epilepsia 1982;234(supp 1):529-541.

  17. Walsh G, Delgado-Escueta AV. Status epilepticus. In: Devinsky O. Neurology clinics, epilepsy I: diagnosis and treatment. W. B. Saunders comp 1993;11: 835-839.

  18. Shorvon S. The classification of status epilepticus. Epileptic Disord 2005:7:1-3.

  19. Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology : report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212-1218.

  20. Trinka E, Höfler J, Zerbs A. Causes of status epilepticus. Epilepsia 2012;53(Suppl 4):127-138.

  21. Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol 2010;67:931-940.

  22. Brailowky S, Silva-Barrat C, Naquet R. Elementos fisiopatológicos de las epilepsias: aportes recientes de la investigación experimental. Salud Mental 1989;12:53-62.

  23. Hallak M, Irtenkauf AS, Janusz C, Cotton D. Stimulation and inhibition of NMDA receptors in rats. Developing a seizure model. AJGO 1993;169:695-699.

  24. Shorvon S, Walker M. Status epilepticus in idiopathic generalized epilepsy. Epilepsia 2005;46(Suppl 9):73-79.

  25. Bozzi Y, Casarosa S, Caleo M. Epilepsy as a neurodevelopment disorder. Front Psychiatry 2012;3:19.

  26. Briggs SW, Galanopoulou AS. Altered GABA signaling in early life epilepsies. Neural Plast 2011;2011.

  27. Losi G, Cammarota M, Carmignoto G. The role of astroglia in the epileptic brain. Front Pharmacol 2012;3:1-13.

  28. Aguiar CC, Almeida AB, Araújo PV, de Abreu RN, Chaves EM, do Vale OC, et al. Oxidative stress and epilepsy: literature review. Oxid Med Cell Longev, 2012.

  29. Friedman A, Heinemann U. Role of blood-brain barrier dysfunction in epileptogenesis. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV. Source Jasper’s Basic Mechanisms of the Epilepsies. 4th edition. Bethesda (MD):National Center for Biotechnology Information, 2012.

  30. Kandel ER, Schwartz JH, Jessell TM. Crisis epilépticas y epilepsias. En: Kandel ER, Schwartz JH, Jessell TM. Principios de Neurociencias. Madrid:Ed. McGraw Hill Interamericana de España, 2001:910-935.

  31. Wasterlain CG, Fujikawa DJ, Larroy P. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34(suppl 1):37-57.

  32. Meierkord H, Weishman U, Niechaus L, Lechman R. Structural consequences of status epilepticus demonstrated with serial magnetic resonance imaging. Acta Neurol Scand 1997;96:127-132.

  33. Engrand N, Crespel A. Pathophysiologic basis of status epilepticus. Rev Neurol 2009;165:315-319.

  34. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34(Suppl 1):37-53.

  35. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41(Suppl 2):23-30.

  36. Prasad K, Al-Roomi K, Krishnan PR, Sequeira R. Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 2005;19(4):CD003723.

  37. Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010;17(3):348-355.

  38. Walker IA, Slovis SM. Lidocaine in treatment of status epilepticus. Acad Emerg Med 1997;4:918-922.

  39. Prasad K, Krishnan PR, Al-Roomi K, Sequeira R. Anticonvulsant therapy for status epilepticus. Br J Clin Pharmacol 200;63:640-647.

  40. Kendall JL, Reynolds M, Goldberg R. Intranasal Midazolam in patients with status epilepticus. Ann E M 1997;29:415-417.

  41. Lal Koul R, Raj Aithala G, Chaco A, Joshi R, Selfy Eubaly M. Continuous midazolam infusion as treatment of status epilepticus. Arch. of disease in childhood 1997;76:445-448.

  42. Leppik JE, Derivan AT, Homan RW. Double-blind study of lorazepam and diazepma in status epilepticus. JAMA 1983;249:1452-1454.

  43. Leppik JE, Boucher BA, Wilder BJ. Pharmacokinetics and safety of a phenytoin prodrug given IM or IV in patients. Neurology 1990;40:456-478.

  44. Eriksson K, Keränen T, Kälviäinen R. Fosphenytoin. Expert Opin Drug Metab Toxicol 2009;5:695-701.

  45. Walker IA, Howard RS, Smith SJ, Miller DH, Shorvon SD, Hirsh NP. Diagnosis and treatment of status epilepticus on neurological intensive care unit. QJM 1996;12:912-920.

  46. Trinka E. What is the evidence to use new intravenous AEDs in status epilepticus? Epilepsia 2011;52(Suppl 8):35-38.

  47. Lowentein DH, Aminoff M J, Simon R. Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology 1988;38:395-400.

  48. Canouï-Poitrine F, Bastuji-Garin S, Alonso E, Darcel G, Verstichel P, Caillet P, et al. Risk and prognostic factors of status epilepticus in the elderly: a case-control study. Epilepsia 2011;52:1849-1856.

  49. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004;11:800-810.

  50. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006;77(5):611-615.




2020     |     www.medigraphic.com